Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 4 studies | 28% ± 9% | |
| oligodendrocyte | 4 studies | 31% ± 8% | |
| macrophage | 4 studies | 26% ± 6% | |
| endothelial cell | 4 studies | 30% ± 10% | |
| epithelial cell | 3 studies | 37% ± 7% | |
| GABAergic neuron | 3 studies | 38% ± 6% | |
| astrocyte | 3 studies | 37% ± 7% | |
| glutamatergic neuron | 3 studies | 44% ± 5% | |
| basal cell | 3 studies | 30% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 42% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7525.86 | 1442 / 1445 | 99% | 11.38 | 181 / 183 |
| uterus | 100% | 11229.01 | 170 / 170 | 98% | 13.05 | 451 / 459 |
| thymus | 100% | 15438.98 | 653 / 653 | 97% | 15.99 | 587 / 605 |
| pancreas | 100% | 6188.70 | 328 / 328 | 97% | 15.55 | 172 / 178 |
| bladder | 100% | 8623.43 | 21 / 21 | 97% | 15.11 | 487 / 504 |
| breast | 100% | 10350.68 | 459 / 459 | 96% | 11.92 | 1069 / 1118 |
| adrenal gland | 100% | 11545.90 | 258 / 258 | 95% | 9.93 | 219 / 230 |
| brain | 97% | 4813.53 | 2560 / 2642 | 98% | 15.90 | 691 / 705 |
| prostate | 100% | 12820.75 | 245 / 245 | 95% | 11.46 | 476 / 502 |
| intestine | 100% | 9386.47 | 966 / 966 | 93% | 9.89 | 492 / 527 |
| lung | 100% | 8958.27 | 577 / 578 | 92% | 13.62 | 1061 / 1155 |
| ovary | 100% | 12001.18 | 180 / 180 | 90% | 9.60 | 387 / 430 |
| stomach | 100% | 7183.90 | 359 / 359 | 90% | 8.88 | 257 / 286 |
| kidney | 100% | 9309.87 | 89 / 89 | 89% | 15.01 | 802 / 901 |
| liver | 100% | 4665.81 | 225 / 226 | 81% | 7.05 | 328 / 406 |
| skin | 100% | 6109.99 | 1805 / 1809 | 78% | 8.73 | 369 / 472 |
| adipose | 100% | 8483.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 13007.48 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.60 | 1 / 1 |
| blood vessel | 100% | 8542.95 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 4275.53 | 844 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 14.75 | 28 / 29 |
| muscle | 85% | 2388.36 | 683 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 6.26 | 35 / 45 |
| peripheral blood | 74% | 3089.27 | 690 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 56% | 6.27 | 45 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006457 | Biological process | protein folding |
| GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
| GO_0005829 | Cellular component | cytosol |
| GO_0051087 | Molecular function | protein-folding chaperone binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0001671 | Molecular function | ATPase activator activity |
| Gene name | AHSA2P |
| Protein name | Putative activator of 90 kDa heat shock protein ATPase homolog 2 (Activator of HSP90 ATPase homolog 2 pseudogene) |
| Synonyms | AHSA2 |
| Description | FUNCTION: Co-chaperone that stimulates HSP90 ATPase activity. . |
| Accessions | Q719I0 |
